Roxadustat for Patients with Chemotherapy Induced Anemia
Español  |  中國傳統的  |  简体中文
Call us  (855) 528-7322
Main Menu

Roxadustat for Patients with Chemotherapy Induced Anemia

Sponsor: FibroGen, Inc.

Protocol FGCL-4592-092. A Phase 2 Open Label Study Investigating the Efficacy and Safety of Roxadustat (FG-4592) for Treatment of Anemia in Patients Receiving Chemotherapy Treatment for Non-Myeloid Malignancies.